Melodiol reports strong start to Q3 as Health House acquisition begins to bed down by Steve Jones July 19, 2023April 30, 2024 Melodiol Global Health has reported A$1.6 million in unaudited revenue in the first six weeks of […]
Creso hits back after ASX questions firm’s ability to remain listed by Steve Jones May 16, 2023April 30, 2024
Company news: Health House; Little Green Pharma; Incannex; Emyria by Steve Jones and Martin Lane April 19, 2023April 30, 2024
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
Vitura Health relishes competition as firm begins ‘phase two’ of growth plan by Steve Jones February 16, 2023April 30, 2024
Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma by Steve Jones and Martin Lane January 31, 2023February 2, 2023
From medicinal cannabis to beer and burgers – with a helping hand from hemp by Steve Jones December 14, 2022December 14, 2022
Greg Hunt was nagging me, asking ‘how fast can you import medicinal cannabis?’ by Steve Jones November 30, 2022April 29, 2024
Creso Pharma secures commitments to raise A$7.6m via convertible notes by Martin Lane November 1, 2022April 29, 2024
Creso presses on with Health House deal after positive due diligence by Steve Jones September 5, 2022April 29, 2024
